Literature DB >> 17344380

Prime time for alpha-synuclein.

Aaron D Gitler1, James Shorter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17344380      PMCID： PMC6672516          DOI： 10.1523/JNEUROSCI.0094-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN： 0270-6474            Impact factor:   6.167


× No keyword cloud information.
  25 in total

1.  Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: autonomic pathway implicated in Parkinson's disease?

Authors:  R J Phillips; G C Walter; S L Wilder; E A Baronowsky; T L Powley
Journal:  Neuroscience       Date:  2008-03-18       Impact factor: 3.590

2.  Common key-signals in learning and neurodegeneration: focus on excito-amino acids, beta-amyloid peptides and alpha-synuclein.

Authors:  L F Agnati; G Leo; S Genedani; L Piron; A Rivera; D Guidolin; K Fuxe
Journal:  J Neural Transm (Vienna)       Date:  2008-11-19       Impact factor: 3.575

3.  Prion-like disorders: blurring the divide between transmissibility and infectivity.

Authors:  Mimi Cushman; Brian S Johnson; Oliver D King; Aaron D Gitler; James Shorter
Journal:  J Cell Sci       Date:  2010-04-15       Impact factor: 5.285

Review 4.  Cell Biology and Pathophysiology of α-Synuclein.

Authors:  Jacqueline Burré; Manu Sharma; Thomas C Südhof
Journal:  Cold Spring Harb Perspect Med       Date:  2018-03-01       Impact factor: 6.915

Review 5.  Defects in trafficking bridge Parkinson's disease pathology and genetics.

Authors:  Asa Abeliovich; Aaron D Gitler
Journal:  Nature       Date:  2016-11-10       Impact factor: 49.962

6.  Potentiating Hsp104 activity via phosphomimetic mutations in the middle domain.

Authors:  Amber Tariq; JiaBei Lin; Megan M Noll; Mariana P Torrente; Korrie L Mack; Oscar Hernandez Murillo; Meredith E Jackrel; James Shorter
Journal:  FEMS Yeast Res       Date:  2018-08-01       Impact factor: 2.796

7.  Evidence that alpha-synuclein does not inhibit phospholipase D.

Authors:  Irit Rappley; Aaron D Gitler; Paige E Selvy; Matthew J LaVoie; Bruce D Levy; H Alex Brown; Susan Lindquist; Dennis J Selkoe
Journal:  Biochemistry       Date:  2009-02-10       Impact factor: 3.162

8.  Microtubule depolymerization suppresses alpha-synuclein accumulation in a mouse model of multiple system atrophy.

Authors:  Kimiko Nakayama; Yasuyo Suzuki; Ikuru Yazawa
Journal:  Am J Pathol       Date:  2009-03-12       Impact factor: 4.307

9.  Lipidomic profiling in mouse brain reveals differences between ages and genders, with smaller changes associated with alpha-synuclein genotype.

Authors:  Irit Rappley; David S Myers; Stephen B Milne; Pavlina T Ivanova; Matthew J Lavoie; H Alex Brown; Dennis J Selkoe
Journal:  J Neurochem       Date:  2009-07-17       Impact factor: 5.372

10.  The Parkinson's disease protein alpha-synuclein disrupts cellular Rab homeostasis.

Authors:  Aaron D Gitler; Brooke J Bevis; James Shorter; Katherine E Strathearn; Shusei Hamamichi; Linhui Julie Su; Kim A Caldwell; Guy A Caldwell; Jean-Christophe Rochet; J Michael McCaffery; Charles Barlowe; Susan Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-27       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.